Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children
Clinical trial NCT03939637 · COMPLETED
Trial details
- NCT number
- NCT03939637
- Sponsor
- Baylor College of Medicine
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-02
- Primary completion
- 2024-04-17
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.